Myasthenia gravis is a prototypical antibody-mediated autoimmune neuromuscular disorder. Treatments have improved over the past 30 years, leading to significantly fewer deaths and better quality of life. Future research should further elucidate its pathogenesis, reveal better ways to diagnose it, and yield new treatments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3949/ccjm.80a.13044 | DOI Listing |
Publication Analysis
Top Keywords
myasthenia gravis
8
gravis newer
4
newer therapies
4
therapies offer
4
offer sustained
4
sustained improvement
4
improvement myasthenia
4
gravis prototypical
4
prototypical antibody-mediated
4
antibody-mediated autoimmune
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!